Literature DB >> 17855541

Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.

Jason L Dehart1, Vicente Planelles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17855541      PMCID： PMC2224437          DOI： 10.1128/JVI.01628-07

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  69 in total

1.  Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint.

Authors:  Leigh Ann A Higa; Ivailo S Mihaylov; Damon P Banks; Jianyu Zheng; Hui Zhang
Journal:  Nat Cell Biol       Date:  2003-10-26       Impact factor: 28.824

2.  Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage.

Authors:  Hengbin Wang; Ling Zhai; Jun Xu; Heui-Yun Joo; Sarah Jackson; Hediye Erdjument-Bromage; Paul Tempst; Yue Xiong; Yi Zhang
Journal:  Mol Cell       Date:  2006-05-05       Impact factor: 17.970

3.  CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.

Authors:  Regina Groisman; Isao Kuraoka; Odile Chevallier; Nogaye Gaye; Thierry Magnaldo; Kiyoji Tanaka; Alexei F Kisselev; Annick Harel-Bellan; Yoshihiro Nakatani
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

4.  HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.

Authors:  W C Goh; M E Rogel; C M Kinsey; S F Michael; P N Fultz; M A Nowak; B H Hahn; M Emerman
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

5.  Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).

Authors:  T M Fletcher; B Brichacek; N Sharova; M A Newman; G Stivahtis; P M Sharp; M Emerman; B H Hahn; M Stevenson
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

6.  Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R.

Authors:  Mikhail Roshal; Baek Kim; Yonghong Zhu; Paul Nghiem; Vicente Planelles
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

7.  Vpr-induced cell cycle arrest is conserved among primate lentiviruses.

Authors:  V Planelles; J B Jowett; Q X Li; Y Xie; B Hahn; I S Chen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 8.  The COP9 signalosome.

Authors:  Ning Wei; Xing Wang Deng
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

9.  Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities.

Authors:  Olivier Leupin; Séverine Bontron; Michel Strubin
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440
View more
  26 in total

1.  The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx.

Authors:  Efrem S Lim; Oliver I Fregoso; Connor O McCoy; Frederick A Matsen; Harmit S Malik; Michael Emerman
Journal:  Cell Host Microbe       Date:  2012-01-26       Impact factor: 21.023

2.  HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.

Authors:  Jean-Philippe Belzile; Jonathan Richard; Nicole Rougeau; Yong Xiao; Eric A Cohen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 3.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

4.  Cell context-dependent involvement of ATR in early stages of retroviral replication.

Authors:  Yi-Xin Yang; Vincent Guen; Jonathan Richard; Eric A Cohen; Lionel Berthoux
Journal:  Virology       Date:  2009-11-13       Impact factor: 3.616

Review 5.  Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase.

Authors:  Bizhan Romani; Eric A Cohen
Journal:  Curr Opin Virol       Date:  2012-10-10       Impact factor: 7.090

6.  From arrest to escape: HIV-1 Vpr cuts a deal.

Authors:  Eric A Cohen
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

Review 7.  Hepatitis B Virus X and Regulation of Viral Gene Expression.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

8.  Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction.

Authors:  Hiroko Kitayama; Yoshiharu Miura; Yoshinori Ando; Shigeki Hoshino; Yukihito Ishizaka; Yoshio Koyanagi
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.

Authors:  Mizuho Nonaka; Yoshie Hashimoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Cancer Cell Int       Date:  2009-08-12       Impact factor: 5.722

10.  HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.

Authors:  Jeffrey Ward; Zachary Davis; Jason DeHart; Erik Zimmerman; Alberto Bosque; Enrico Brunetta; Domenico Mavilio; Vicente Planelles; Edward Barker
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.